[Federal Register Volume 71, Number 39 (Tuesday, February 28, 2006)]
[Notices]
[Pages 10043-10044]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-2761]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Center for Substance Abuse Prevention; Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given of the 
meeting of the Substance Abuse and Mental Health Services 
Administration (SAMHSA) Drug Testing Advisory Board on March 7-8, 2006.
    A portion of the meeting will be open and will include a roll call, 
general announcements, a Department of Health and Human Services drug 
testing program update, a Department of Transportation drug testing 
program update, and a Nuclear Regulatory Commission drug testing 
program update.
    Attendance by the public will be limited to space available. Public 
comments are welcome. Please communicate with the individual listed 
below as contact to make arrangements to comment or to request special 
accommodations for persons with disabilities.

[[Page 10044]]

    The Board will also meet to develop the final revisions to the 
proposed Mandatory Guidelines for Federal Workplace Drug Testing 
Programs that were published in the Federal Register on April 13, 2004 
(69 FR 19673) and to discuss Federal agency specimen results, 
confirmatory drug test issues, specimen validity test issues, 
laboratory inspection issues, and analytical instrumentation issues. 
This meeting will be conducted in closed session since discussing these 
issues in open session will significantly frustrate the Department's 
ability to develop the revisions to the Mandatory Guidelines or to 
disclose information of a personal nature where disclosure would 
constitute an unwarranted invasion of personal privacy. The HHS Office 
of General Counsel made the determination that such matters are 
protected by exemptions (6) and 9(B) of section 552b(c) of title 5 
U.S.C. and therefore may be closed to the public.
    To facilitate entering the building for the open session, public 
attendees are required to contact Mrs. Giselle Hersh, Division of 
Workplace Programs, 1 Choke Cherry Road, Room 2-1042, Rockville, MD 
20857, 240-276-2605 (telephone) or by e-mail to 
[email protected].
    Substantive program information and a roster of Board members may 
be obtained by accessing the SAMHSA workplace Web site (http://workplace.samhsa.gov) or communicating with the contact whose name and 
telephone number are listed below. The transcript for the open session 
will be available on the SAMHSA workplace Web site as soon as possible 
after the meeting.
    Committee Name: Substance Abuse and Mental Health Services 
Administration Drug Testing Advisory Board.
    Meeting Date: March 7-8, 2006.
    Place: SAMHSA Building, Sugarloaf Room, 1 Choke Cherry Road, 
Rockville, Maryland 20850.
    Type: Open: March 7, 2006; 8:30 a.m.-11:30 a.m., Closed: March 7, 
2006; 11:30 a.m.-4:30 p.m., Closed: March 8, 2006; 8:30 a.m.-Noon.
    Contact: Donna M. Bush, Ph.D., Executive Secretary, 1 Choke Cherry 
Road, Room 2-1033, Rockville, Maryland 20857, 240-276-2600 (telephone) 
and 240-276-2610 (fax), E-mail: [email protected].

    Dated: February 20, 2006.
Toian Vaughn,
Committee Management Officer, Substance Abuse and Mental Health 
Services Administration.
[FR Doc. E6-2761 Filed 2-27-06; 8:45 am]
BILLING CODE 4162-20-P